TILRAY Aktie

>TILRAY Aktienkurs

4.265 EUR -4.6% (TradegateBSX)

Ask: 4.305 EUR / 4700 Stück

Bid: 4.275 EUR / 4700 Stück

Tagesumsatz: 63162 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

TILRAY Aktie über LYNX handeln

Intraday

1 Jahr

>TILRAY Performance

1 Woche: -9,3%

1 Monat: -12,5%

3 Monate: -30,1%

6 Monate: 0%

1 Jahr: 0%

laufendes Jahr: 0%

>TILRAY Aktie

Name:

TILRAY BRANDS INC.

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US88688T2096 / A41VMJ

Symbol/ Ticker:

2HQ0 (Frankfurt) / TLRY (NASDAQ)

Kürzel:

FRA:2HQ0, ETR:2HQ0, 2HQ0:GR, NASDAQ:TLRY

Index:

Webseite:

https://www.tilray.com/

Profil:

Marktkapitalisierung:

530.44 Mio. EUR

Unternehmenswert:

547.93 Mio. EUR

Umsatz:

744.89 Mio. EUR

EBITDA:

16.43 Mio. EUR

Nettogewinn:

-1166.99 Mio. EUR

Gewinn je Aktie:

-11.86 EUR

Schulden:

275.19 Mio. EUR

Liquide Mittel:

216.54 Mio. EUR

Operativer Cashflow:

Bargeldquote:

1.03

Umsatzwachstum:

-8.82%

Gewinnwachstum:

-24.87%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

TILRAY

Letzte Datenerhebung:

08.06.26

>TILRAY Kennzahlen

Aktien/ Unternehmen:

Aktien: 119.6 Mio. St.

Frei handelbar: 99.27%

Leerverk. Aktien: 14.06%

Rückkaufquote: -16.32%

Mitarbeiter: 2842

Umsatz/Mitarb.: 0.25 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 82.4%

Bewertung:

KGV: -

KGV lG: -

KUV: 0.66

KBV: 0.4

PEG-Ratio: -0.01

EV/EBITDA: 33.36

Rentabilität:

Bruttomarge: 23.71%

Gewinnmarge: -156.67%

Operative Marge: -7.39%

Managementeffizenz:

Gesamtkaprendite: -49.09%

Eigenkaprendite: -62.73%

>TILRAY Peer Group

Gesundheit

>TILRAY Chart & Kurs - NASDAQ
- Boerse Frankfurt
- Gettex
- NASDAQ
- Tradegate
- Xetra
- >Profi Charts

>TILRAY News

08.06.26 - 02:48	Is Tilray′s Brewdog Bet Already Backfiring? Collapsing UK Sales Suggest Yes. (Fool)
	Tilray bought Brewdog on the cheap, but there's a reason why it got such a good price....

03.06.26 - 01:45	Tilray Brands, Inc. (TLRY) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
	The latest trading day saw Tilray Brands, Inc. (TLRY) settling at $5.38, representing a -2% change from its previous close....

27.05.26 - 09:12	Tilray Stock Has Crashed 90%. Could Marijuana Rescheduling Spark a Massive Comeback? (Fool)
	Don't hold your breath....

27.05.26 - 08:00	Tilray Looks Ready for a Breakout -- If 1 Thing Goes Right (Fool)
	The bull case still hinges on legalization's progress....

26.05.26 - 08:03	Tilray Medical Brings Global Medical Cannabis Expertise to Cannabis Europa London 2026 (GlobeNewswire EN)
	Industry Leaders Convene on the Future of Medical Cannabis Regulation and Patient Access Industry Leaders Convene on the Future of Medical Cannabis Regulation and Patient Access...

20.05.26 - 14:36	Tilray, Canopy & Co. bangen: Cannabis-Aktien droht der Super-GAU: Anleger machen jetzt fatalen Fehler, wenn (Wallstreet-Online)
	Die Uhr tickt. Der Countdown läuft. Der Cannabis-Sektor steuert auf seine ultimative Entfesselung zu oder steuert direkt ins Chaos. Zwischen diesen beiden Extremen wird es sich wohl entscheiden. ...

11.05.26 - 16:12	It′s Been 5 Years Since Tilray Merged With Aphria to Create a "Global Cannabis Leader." Here′s How It′s Done Since Then (Fool)
	Tilray's business has gotten bigger over the years, but it continues to struggle with achieving profitability....

07.05.26 - 21:36	1 Wall Street Analyst Thinks Tilray Will Soar Nearly 75%. Is It a Buy Now? (Fool)
	International growth could make up for a lack of U.S. legalization progress...

07.05.26 - 00:00	Is Tilray the Best Value Play in the $7.4 Billion Cannabis Beverage Market? (Fool)
	Or is it just a value trap?...

04.05.26 - 03:00	Why Tilray′s Marijuana Rescheduling Sizzle Has Fizzled (Fool)
	Most regulatory headwinds remain for cannabis companies like Tilray....

02.05.26 - 19:00	Tilray Brands to Expand Into the U.S. Marijuana Market? Why You Shouldn′t Count on That Anytime Soon (Fool)
	Marijuana rescheduling may have taken place in the U.S., but that doesn't mean legalization will happen anytime soon....

25.04.26 - 11:12	Is Tilray a Textbook Example of a Value Trap? (Fool)
	Tilray doesn't fit squarely into the value trap or value stock categories....

23.04.26 - 17:57	Tilray Smells Opportunity After Historic Cannabis Policy Shift (Benzinga)
	Tilray Brands eyes U.S. expansion as cannabis reclassification to Schedule III creates new opportunities for growth and clinical research. Importance Rank: 1 read more...

23.04.26 - 17:42	Aktien von Tilray, Canopy Growth & Co. drehen ins Minus: Neueinstufung von Cannabis offenbar in Kürze (Finanzen.net)
	Zahlreiche Cannabis-Aktien legten am Mittwoch zweistellig zu. Der Kursschub ist dabei eng mit einem möglichen historischen Schritt der US-Regierung verknüpft....

23.04.26 - 15:36

Tilray Surges 10%: Rescheduling Momentum Builds as Traders Await Official Confirmation (24/7 Wall St.)

Shares of Tilray Brands (NASDAQ:TLRY) are up roughly 10% in early Thursday trading, changing hands near $8.68 after the stock closed up 14% at $7.87 on Wednesday. The catalyst is growing speculation that the administration is preparing to reclassify marijuana to a less-dangerous drug category, a regulatory tailwind cannabis investors have been waiting on for ... Tilray Surges 10%: Rescheduling Momentum Builds as Traders Await Official Confirmation...

23.04.26 - 14:57	Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis Rescheduling (GlobeNewswire EN)
	Tilray Medical Poised to Accelerate U.S. Medical Cannabis Access for Patients Tilray Medical Poised to Accelerate U.S. Medical Cannabis Access for Patients...

23.04.26 - 08:36	Aktien von Tilray, Canopy Growth & Co. im Höhenflug: Neueinstufung von Cannabis offenbar in Kürze (Finanzen.net)
	Zahlreiche Cannabis-Aktien legten am Mittwoch zweistellig zu. Der Kursschub ist dabei eng mit einem möglichen historischen Schritt der US-Regierung verknüpft....

23.04.26 - 05:01	Insiderhandel: Aufsichtsrat verkauft Aktien von Tilray im Wert von 232879 USD (Insiderkauf)
	Hopkinson, David G. - Aufsichtsrat - Tag der Transaktion: 2026-04-21...

22.04.26 - 23:06	Tilray CEO on Possible US Cannabis Reclassification (Bloomberg)
	Tilray CEO Irwin Simon discusses the expected easing of cannabis restrictions in the US, and why despite not currently selling cannabis in the United States the opportunity to do so would be 'tremendous.' He talks with Romaine Bostick and Katie Greifeld on "the Close." (Source: Bloomberg)...

22.04.26 - 20:54	Tilray and other cannabis stocks soar as Trump is reportedly ready to reclassify the substance (MarketWatch)
	The move, which could open up medical research on cannabis as well as banking services for growers, follows an executive order to reclassify the substance in December....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: In alten Schlössern spucken die Geister am liebsten. - Sprichwort Deutschland

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram